Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Schizophrenia: Treatment

Description: Psychotic disorders are very serious, debilitating diseases characterized by the disintegration and disruption of adaptive behavior and a loss of contact with reality. Schizophrenia is a psychiatric illness that has been much more thoroughly researched than other disorders. It involves a decline in functioning and hallucinations, delusions, and/or disturbed thought processes with symptoms persisting at least six months. This course will review the prognosis and treatment of schizophrenia.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Development Phases
6. Disease Course
7. Progress Check

PHARMACOTHERAPY
8. Objectives
9. Typical Antipsychotics
10. Atypical Antipsychotics
11. Progress Check

PSYCHOTHERAPY
12. Objectives
13. Psychosocial Treatments
14. Progress Check

CONCLUSION
15. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the connection between progression of the illness and time of onset of schizophrenia
  • Explain the diverse types of onset and various courses the disease can take
  • Describe the premorbid and prodromal stages of schizophrenia
  • Explain the pathophysiology of schizophrenia
  • Explain the subtypes of typical and atypical antipsychotic medications used in the treatment of schizophrenia
  • List the side effects of these pharmacologic agents
  • Understand the diverse psychosocial interventions for schizophrenia
  • Explain the goals and benefits of each type of intervention

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

 

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy